Tani reports, “The focus of the story is a company called Safety Shot, which makes a drink it claims lowers blood alcohol content and can quickly sober up people who have been drinking. Hunterbrook’s report, edited by founder Sam Koppelman, said the product didn’t work.
“But Hunterbrook’s story did not disclose that Koppelman is an investor in another company in the same space, ZBiotics. Koppelman acknowledged, after Semafor reviewed documents showing the investment, that he has a small personal stake in the supplement startup, which on its website promises to help drinkers prevent hangovers.
“The pitch is not unlike that made by Safety Shot. While Hunterbrook’s article focuses on Safety Shot’s claim that it sobers you up after drinking, Safety Shot also markets itself as a hangover cure or preventer, the crux of ZBiotics’ product.”
Read more here.
Bloomberg News has hired Gabriella Borter as a political breaking news editor in Washington. Borter was at…
The Information is the go-to source of in-depth reporting for the most influential leaders in…
The Fund for American Studies and The Wall Street Journal announced Tuesday that Kate Farmer,…
The parent company of Reuters that is erasing “diversity” references and “clarifying some of [its]…
Conway Gittens, an anchor at TheStreet.com, has left the news organization after a year. He…
Morning Consult and American City Business Journals have launched the Metropolitan Consumer Sentiment Index, a…